Provided by Tiger Trade Technology Pte. Ltd.

Galmed Pharmaceuticals

4.63
+0.805021.05%
Post-market: 4.660.0300+0.65%19:56 EDT
Volume:303.32K
Turnover:1.24M
Market Cap:4.82M
PE:-0.33
High:4.63
Open:3.91
Low:3.82
Close:3.83
52wk High:13.20
52wk Low:3.29
Shares:1.04M
Float Shares:974.73K
Volume Ratio:21.40
T/O Rate:31.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.1059
EPS(LYR):-19.1292
ROE:-68.21%
ROA:-30.19%
PB:0.38
PE(LYR):-0.24

Loading ...

Galmed Announces First Time Results in Prostate Oncology Studies: Aramchol Demonstrates 3-4 Fold Increase in Cell Death Compared to Enzalutamide (Xtandi®) Alone in Prostate Cancer Models

THOMSON REUTERS
·
Aug 17

Galmed Pharmaceuticals to Execute 1-for-8 Reverse Share Split Aug. 19, 2026

Reuters
·
Aug 15

Galmed Pharmaceuticals Wins Nasdaq Extension to Regain $1 Bid Price Compliance

TIPRANKS
·
Aug 01

Galmed Pharmaceuticals: as a Result of Termination, All Rights to Licensed Technology Will Revert to Yissum

THOMSON REUTERS
·
Jul 30

Galmed Pharmaceuticals: Co's Unit's Obligation to Fund Ongoing Patent Expenses Relating to Licensed Patents Will Cease Effective July 31

THOMSON REUTERS
·
Jul 30

Galmed Pharmaceuticals: Co's Unit & Yissum Entered into Mutual Termination Letter to Terminate License Agreement, Dated June 28, 2021

THOMSON REUTERS
·
Jul 30

Galmed’s Aramchol ODF formulation shows positive results in Parkinson’s

TIPRANKS
·
Jul 28

Galmed Says Aramchol Oral Film Boosts Bioavailability 150%, CNS Exposure 300% in Parkinson’s Program

Reuters
·
Jul 28

Galmed Pharmaceuticals Unveils Cardiac-Targeted Aramchol LNP Breakthrough

TIPRANKS
·
Jul 17

Galmed Partners with Barcode Nanotech on Heart-targeted Aramchol LNP Formulation

Reuters
·
Jul 16

Galmed Announces the Breakthrough Development of Novel Lnp Cardiac Targeted Formulation of Its Scd1 Inhibitor, Aramchol

THOMSON REUTERS
·
Jul 16

Galmed Pharmaceuticals Reports Wider Q1 2026 Loss Amid Higher R&D Spending

TIPRANKS
·
Jul 09

Galmed Pharmaceuticals Buys Colospan in Deal Valued up to $5.3 Million

Reuters
·
Jul 09

Galmed Pharmaceuticals Completes Acquisition of Colospan Under Restructured Deal

MT Newswires Live
·
Jun 22

BRIEF-Galmed Pharmaceuticals Ltd. Announces Restructured Acquisition Terms For Colospan Ltd.

Reuters
·
Jun 22

Galmed restructures Colospan deal terms, swaps $2 million share payment for earnout and extra cash

Reuters
·
Jun 22

Galmed Pharmaceuticals - Increases Cash Payment by $800K, Restructures $2 Mln Earnout Starting Q3 2027

THOMSON REUTERS
·
Jun 22

Galmed Pharmaceuticals Ltd. Announces Restructured Acquisition Terms for Colospan Ltd., Prioritizing CG-100 European Commercialization and Shareholder Value Protection and Consummation of Acquisition

THOMSON REUTERS
·
Jun 22

Analysts Have Conflicting Sentiments on These Healthcare Companies: Autolus Therapeutics (AUTL), Galmed Pharmaceuticals (GLMD) and Oculis Holding (OCS)

TIPRANKS
·
Jun 11

Galmed Pharmaceuticals to Acquire Colospan and Commit $6 Million to European Expansion

TIPRANKS
·
Jun 08